Page results
-
A minimally invasive technique for treating prostate cancer has been used for the first time in the NHS at UCLH. It can be used with precision to treat the affected area, reducing side effects.
-
UCLH consultant Dr Arjuna Nagendran featured in the Royal Institution’s prestigious series on Boxing Day; this year presented by Professor Mike Woolridge on artificial intelligence (AI).
-
Dr Matthew Adams is a consultant radiologist with a special interest in stroke, movement disorders and neurogenetics.
-
Men currently attending a hospital outpatient clinic for prostate hormone injections every 3 or 6 months will be advised that (unless not clinically appropriate) their next injection will be administered at a local GP practice, usually by the practice nurse.
-
All semen analysis referrals should be made via the NHS e-Referral Service (e-RS). We will no longer be able to book semen analysis appointments through direct requests from patients or GP surgeries via email.
-
We are now administering new COVID-19 treatments for patients at highest risk in the community. The service can prescribe oral antivirals to be taken at home, and give intravenous antibody treatments at the hospital.
-
I became a volunteer with the Trust in early 2022, after I retired from a career in family law, initially practising as a barrister and later as a District Judge of the Central Family Court.
-
The court has granted permission to appeal a High Court ruling relating to puberty-blocking treatment in cases of gender dysphoria.
-
This page explains what Post-COVID-19 Syndrome is.
-
Whilst the UCLH paediatric emergency department remains on divert, access for GPs to paediatrics remains available as usual.
File results
-
FOI/2024/0401 - Hospital treatments for abortion complications
-
FOI/2024/0402 - Various IT systems used at the Trust
-
FOI/2024/0403 - Risk Policy and corporate risk register
-
FOI/2024/0406 - Staff and patient discrimination complaints in 2021, 2022 and 2023
-
FOI/2024/0409 - Number of A&E attendees with mental health complaints from 2022 to 2024
-
FOI/2024/0412 - Healthcare travel costs scheme for patients
-
FOI/2024/0415 - Biologic and targeted medications within dermatology medicine
-
FOI/2024/0416 - Home dialysis treatment
-
FOI/2024/0417 - Funding for point-of-care home blood monitoring devices for cancer patients
-
FOI/2024/0420 - Commercialisation of NHS patient data